{"entity":{"id":"onj-cancer-centre","kind":"institution","name":"Olivia Newton-John Cancer Wellness and Research Centre","aka":["ONJ Centre","Olivia Newton-John Cancer Research Institute","Austin Health"],"tldr":"The Olivia Newton-John Cancer Centre at Melbourne's Austin Hospital runs one of Australia's busiest phase 1 units for immunotherapies and antibody-drug conjugates; its research institute grew out of the Ludwig Institute's Melbourne branch and leads antibody PET, FAPI and PSMA imaging work.","summary":"The Olivia Newton-John Cancer Wellness and Research Centre opened at Austin Health in Heidelberg, Melbourne, in 2012, and the Olivia Newton-John Cancer Research Institute (a La Trobe University school of cancer medicine) grew out of the Melbourne branch of the Ludwig Institute for Cancer Research, which produced landmark tumour immunology and antibody work under Andrew Scott and Jonathan Cebon. The centre runs one of Australia's busiest phase 1 units for immunotherapies and antibody-drug conjugates, hosts a leading molecular imaging programme (antibody PET, FAPI and PSMA imaging), and combines cancer care with a wellness model that includes exercise and supportive therapies. Its investigators have led international trials in gastrointestinal cancers, melanoma and glioma.","asOf":"2026-09-09","links":[{"label":"ONJ Cancer Centre","url":"https://www.onjcancercentre.org"},{"label":"Olivia Newton-John Cancer Research Institute","url":"https://www.onjcri.org.au"}],"tags":[],"related":[],"cancers":["melanoma","colorectal","glioblastoma","gastric"],"sections":["immunotherapy","imaging","supportive-care"],"technologies":["immuno-pet","checkpoint-inhibitor","adc","exercise-oncology"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["marco-herold"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Melbourne","country":"AU","lat":-37.756,"lng":145.06,"institutionType":"cancer-center","website":"https://www.onjcancercentre.org","university":"La Trobe University","programs":["Phase 1 immunotherapy trials","Tumour immunology (Ludwig lineage)","Molecular imaging","Wellness and supportive care"]},"route":"/institutions/onj-cancer-centre/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"gastric","kind":"cancer","name":"Gastric & gastro-oesophageal junction cancer","route":"/cancers/gastric/"},{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"}],"section":[{"id":"imaging","kind":"section","name":"Imaging","route":"/fronts/imaging/"},{"id":"immunotherapy","kind":"section","name":"Immunotherapy","route":"/fronts/immunotherapy/"},{"id":"supportive-care","kind":"section","name":"Supportive Care & Survivorship","route":"/fronts/supportive-care/"}],"technology":[{"id":"adc","kind":"technology","name":"Antibody-drug conjugate (ADC)","route":"/technologies/adc/"},{"id":"exercise-oncology","kind":"technology","name":"Exercise & lifestyle oncology","route":"/technologies/exercise-oncology/"},{"id":"checkpoint-inhibitor","kind":"technology","name":"Immune checkpoint inhibitors","route":"/technologies/checkpoint-inhibitor/"},{"id":"immuno-pet","kind":"technology","name":"Immuno-PET","route":"/technologies/immuno-pet/"}],"person":[{"id":"marco-herold","kind":"person","name":"Marco Herold","route":"/people/marco-herold/"}]}}